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Abstract
We report herein the disappearance of macular hard exudates after the introduction of hemodial-
ysis in diabetic patients. A 62-year-old woman and a 52-year-old man with diabetes mellitus
showed hard exudates in the macula of the left eyes. Both patients had previously undergone
panretinal photocoagulation in both eyes. During the follow-up, hemodialysis was introduced for
deteriorating chronic renal failure caused by diabetic nephropathy. Half a year later, macular hard
exudates in the left eyes disappeared dramatically in both patients, but the visual acuity remained
the same. No additional laser treatment was done during the observation period. Hemodialysis
is considered to have accelerated the resolution of macular hard exudates in both patients. The
deposition of macular hard exudates in diabetic patients is due in part to concurrent poor renal
function.
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acular hard exudate deposition is a sight-
threatening consequence of macular edema in 
patients with diabetes mellitus [1].  In this study, 
macular hard exudates disappeared in 2 patients with 
diabetes mellitus after the introduction of hemodialy-
sis.
Case Report
　　Case 1. 　A 59-year-old woman with a 10-year 
history of diabetes mellitus was ﬁ rst seen at 
Okayama University Hospital in December 1997. 
Diabetes was controlled with oral glibenclamide 
1.25 mg daily,  and hypertension was controlled with 
temocapril 2 mg daily.  The patient underwent pan-
retinal photocoagulation in both eyes at another hos-
pital in May 1997.  Her best-corrected visual acuity 
was 0.2 in the right eye and 0.05 in the left eye.  She 
had diﬀ use macular edema in the right eye and mas-
sive hard exudates in the macula of the left eye.  In 
March 1998,  she underwent vitrectomy combined 
with cataract surgery for diﬀ use macular edema in 
the right eye and then cataract surgery alone in the 
left eye.  Her best-corrected visual acuity was 0.7 in 
the right eye and 0.1 in the left eye.  In November 
2000,  the patient began to undergo hemodialysis 
twice a week for chronic renal failure resulting from 
diabetic nephropathy (Table 1).  Recombinant human 
erythropoietin (epoetin beta) was used.  In May 2001, 
half a year after the start of hemodialysis,  she 
showed no hard exudates in the macula of the left eye 
(Fig.  1).  The visual acuity in the left eye remained 
the same.  No additional laser treatment was per-
formed after the start of hemodialysis.
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We report herein the disappearance of macular hard exudates after the introduction of hemodialysis 
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Fig. 1　　Case 1.  Fundus photographs in the right eye (left column) and left eye (right column) before the introduction of hemodialysis 
(top,  November 2000) and half a year after the start of hemodialysis (bottom,  May 2001).  The macular hard exudates in the left eye 
have almost disappeared after half a year,  even with no laser treatment.
Table 1　　Laboratory data in two patients before and after the introduction of hemodialysis
Case 1 Case 2
August 2000# May 2001(under hemodialysis) January 1999#
October 1999
(under hemodialysis)
Total protein (g/dL) 4.88 5.28 5.20 5.57
Albumin (g/dL) 2.65 2.85 2.96 3.10
Total cholesterol (mg/dL) 219 229 229 201
Creatinine (mg/dL) 5.1 N.A. 4.36 N.A.
Urea nitrogen (mg/dL) 36.3 N.A. 40.0 N.A.
24-hour creatinine clearance (L/day) 9.1 N.A. 9.4 N.A.
Red blood cells (x106/microL) 2.95 3.33 2.84 3.74
Hemoglobin (g/dL) 9.9 10.7 9.0 10.9
Hemoglobin A1c (%) 6.6 6.3 6.3  6.5
Blood pressure (mmHg) 154/94 160/90 162/100 176/90
#Before the introduction of hemodialysis.  N.A.,  not applicable under hemodialysis.
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　　Case 2. 　A 51-year-old man with a 15-year his-
tory of diabetes mellitus was ﬁ rst seen at Okayama 
University Hospital in June 1998.  Diabetes was con-
trolled well with diet,  and hypertension was con-
trolled with amlodipine besilate 5 mg daily and temo-
capril 2 mg daily.  The patient underwent panretinal 
photocoagulation in both eyes in 1996,  and under-
went vitrectomy combined with cataract surgery for 
vitreous hemorrhage in the left eye in January 1998 
at another hospital.  His best-corrected visual acuity 
was hand movement in the right eye and 0.1 in the 
left eye.  Vitreous hemorrhage prevented visualiza-
tion of the right fundus,  while the left eye had macu-
lar hard exudates.  In July 1998,  the patient under-
went vitrectomy combined with cataract surgery,  and 
he gained visual acuity of 1.0 in the right eye.  In 
April 1999,  he began undergoing hemodialysis 3 
times a week for chronic renal failure caused by dia-
betic nephropathy (Table 1).  Recombinant human 
erythropoietin (epoetin beta) was used.  The macular 
hard exudates in the left eye apparently decreased in 
October 1999,  half a year after the start of hemodi-
alysis (Fig.  2).  The visual acuity in the left eye 
remained the same.  No additional laser treatment 
was applied to the macular area in the left eye during 
follow-up.
Discussion
　　Serum lipid-lowering has been known to reduce 
hard exudates in diabetic retinopathy [2ﾝ5]. 
Treatment with cholesterol synthesis inhibitors [2, 
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Fig. 2　　Case 2.  Fundus photographs in the right eye (left column) and left eye (right column) before the introduction of hemodialysis 
(top,  April 1999) and half a year after the start of hemodialysis (bottom,  October 1999).  The macular hard exudates in the left eye have 
almost disappeared after half a year,  even with no laser treatment.
3
Matsuo: Disappearance of diabetic macular hard exudates after
Produced by The Berkeley Electronic Press, 2006
4,  5],  heparin-induced extracorporal LDL-
precipitation [3],  and plasmapheresis [4] have been 
reported to induce the resolution of hard exudates. 
In the present study,  the 2 patients were followed in 
a 3-month to 6-month interval,  and macular hard exu-
dates in the left eyes of both patients disappeared 
dramatically in half a year after the introduction of 
hemodialysis.
　　Both patients had received panretinal photocoagu-
lation about 3 years previous to the introduction of 
hemodialysis and had not undergone additional laser 
applications.  For the right eyes,  both patients had 
undergone vitrectomy relatively recently.  In con-
trast,  for the left eyes,  Case 1 had cataract surgery 
only while Case 2 had previously undergone vitrec-
tomy.  In general,  macular edema and hard exudates 
do regress spontaneously,  particularly in eyes which 
have had panretinal photocoagulation [6] and/or vit-
rectomy [7ﾝ12].  The resolution of macular hard 
exudates in the right eyes of both patients might, 
therefore,  have been the consequence of recent vit-
rectomy.  Other factors,  however,  must be consid-
ered as a cause of hard exudate resolution,  espe-
cially in the left eye of Case 1,  which had not 
undergone vitrectomy.  Furthermore,  macular hard 
exudate regression in the left eye of Case 2 could not 
necessarily be attributed to vitrectomy alone,  which 
had been performed almost 2 years previously.
　　Before the start of hemodialysis,  the patients 
were in a state of chronic renal failure and in the 
lower threshold of renal function,  as evidenced by 
24-hour endogenous creatinine clearance of less than 
10 L/day (Table 1).  They had high levels of serum 
creatinine and urea nitrogen as well as abnormal lev-
els of electrolytes (Table 1).  Diabetes mellitus was 
relatively well controlled in both patients,  as indi-
cated by the 6ｵ levels of hemoglobin A1c (Table 1), 
although the index is not completely reliable in the 
presence of anemia and with the use of erythropoetin. 
The patients neither took oral lipid-lowering drugs 
nor showed higher levels of serum cholesterol before 
and after the introduction of hemodialysis (Table 1). 
The regression of macular hard exudates in these 
patients could,  therefore,  be attributed in part to 
the normalization of blood constituents after the 
introduction of hemodialysis rather than to the lipid-
lowering eﬀ ect,  as described in previous studies [2, 
4,  5].  Another mechanism for macular hard exudate 
resolution is the improved function of retinal vascu-
lar cells and retinal pigment epithelial cells in 
response to hemodialysis,  contributing to normaliza-
tion of the blood-retinal barrier.  Such changes,  in 
turn,  might lead to better control of vascular perme-
ability and then to the regression of macular hard 
exudates.
　　Until now,  hemodialysis has been thought to 
improve diabetic macular edema in a few selected 
cases [13,  14].  More recently,  however,  hemodialy-
sis has been shown to be ineﬀ ective in improving 
macular leakage on ﬂ uorescein angiography 4 weeks 
after the beginning of hemodialysis in a prospective 
study involving 22 diabetic patients [15].  These 
studies have attempted to record the change in macu-
lar edema,  but not in macular hard exudates. 
Macular hard exudates are the consequence of macu-
lar edema,  but are not necessarily in temporal asso-
ciation with macular edema.  Macular hard exudates 
would remain even after the resolution of macular 
edema,  as shown in the present series of patients. 
One reason for the failure in improving macular 
edema in the previous study [15] would be the short, 
4-week observation period after the beginning of 
hemodialysis.  In contrast,  the 2 patients in this 
study showed the resolution of macular hard exu-
dates half a year after the beginning of hemodialysis. 
Unfortunately,  the course of the resolution remains 
unknown in the present patients since they were not 
seen during the half-year period after the introduc-
tion of hemodialysis.
　　In conclusion,  the deposition of macular hard exu-
dates in diabetic patients is due in part to concurrent 
poor renal function.  Other systemic factors such as 
renal hypertension and nephrotic hypoproteinemia 
must also be considered as underlying causes. 
Because of the multifactorial nature of the condition, 
further observation with additional cases is neces-
sary to establish a causal relationship between hemo-
dialysis and hard exudate resolution.
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